Depression, use of medical services and cost-offset effects

Journal of Psychosomatic Research

Volumn 42, Issue 4, 1997, Pages 333-344

  Simon, Gregory E ^a,c   Katzelnick, David J ^b  

^a CENTER FOR HEALTH STUDIES   (United States)

^b Dean Foundation for Health   (United States)

^c CENTER FOR HEALTH STUDIES   (United States)

Author keywords

Cost; Cost effectiveness; Cost offset; Depression; Utilization

Indexed keywords

ANTIDEPRESSANT AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

COST CONTROL; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DEPRESSION; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MEDICAL SERVICE; MENTAL HEALTH; PREVALENCE; REVIEW; SAMPLE;

COST-BENEFIT ANALYSIS; DEPRESSIVE DISORDER; HEALTH MAINTENANCE ORGANIZATIONS; HUMANS; MENTAL HEALTH SERVICES; PATIENT ACCEPTANCE OF HEALTH CARE;

EID: 0030957102     PISSN: 00223999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3999(96)00367-4     Document Type: Review

References (55)

1. Kessler R, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-IIIR psychiatric disorders in the United States. Arch Gen Psychiatry 1994;51:8-19.
2. Ormel J, VonKorff M, Ustun TB, Pini S, Korten A, Oldehinkel T. Common mental disorders and disability across cultures. JAMA 1994;272:1741-1748.
3. Klerman G, Weissman M. The course, morbidity, and costs of depression. Arch Gen Psychiatry 1992;49:831-834.
4. Regier DA, Hirschfeld RM, Goodwin FK, Burke JD, Lazar JB, Judd LL. The NIMH Depression Awareness. Recognition and Treatment Program: structure, aims, and scientific basis. Am J Psychiatry 1988;145:1351-1357.
5. Magruder K, Norquist GS, Feil MB, Kopans B, Jacobs D. Who comes to a voluntary depression screening program? Am J Psychiatry 1995;152:1615-1622.
6. Kramer P. Listening to Prozac. New York: Viking 1993.
7. Behavior: feeling good with Prozac: can happiness - and personality - come packaged in a pill? Time Oct 11, 1993;142(126):61.
8. The mind: the promise of Prozac. Newsweek Mar 26, 1990;115(13):38.
9. Glass R. Mental disorders: quality of life and inequality of insurance coverage. JAMA 1995;274:1557.
10. Glaser M. Annual rx survey: rx sales hit new high. Drug Topics 1995;139:43-48.
11. Regier D, Narrow WE, Rae DS, Mandersheid RW, Locke BZ, Goodwin FK. The de facto US mental and addictive disorders service system: epidemiologic catchment area prospective 1-year prevalence rates of disorders and services. Arch Gen Psychiatry 1993;50:85-94.
12. Barsky A, Borus JF. Somatization and medicalization in the era of managed care. JAMA 1995;274:1931-1934.
13. Sturm R, Wells KB. How can care for depression become more cost-effective? JAMA 1995;273:51-58.
14. Kessler LG, Burns BJ, Shapiro S, et al. Psychiatric diagnoses of medical service users: evidence from the Epidemiologic Catchment Area program. Am J Pub Health 1987;77:18-24.
15. Simon G. Psychiatric disorder and functional somatic symptoms as predictors of health care use. Psychiatric Med 1992;10:49-60.
16. Manning W, Wells KB. The effects of psychological distress and psychological well-being on use of medical services. Med Care 1992;30:541-553.
17. Simon G, VonKorff M, Barlow W. Health care costs of primary care patients with recognized depression. Arch Gen Psychiatry 1995;52:850-856.
18. Simon G, Ormel J, VonKorff M, Barlow W. Healthcare costs associated with depressive and anxiety disorders in primary care. Am J Psychiatry 1995;152:352-357.
19. Callahan C, Hui SL, Nienaber NA, Musick BS, Tierney WM. Longitudinal study of depression and health service use among elderly primary care patients. J Am Geriatric Soc 1994;42:833-838.
20. Miranda J, Perez-Stable EJ, Munoz RF, Hargreaves W, Henke CJ. Somatization. psychiatric disorder, and stress in utilization of ambulatory medical services. Health Psychol 1991;10:46-51.
21. Levenson J, Hamer RM, Rossiter LF. Relation of psychopathology in general medical inpatients to use and cost of services. Am J Psychiatry 1990;147:1498-1503.
22. McFarland BH, Freeborn DK, Mullooly JP, Pope CR. Utilization patterns among long-term enrollees in a prepaid group practice health maintenance organization. Med Care 1985;23:1221-1233.
23. Katon W, VonKorff M, Lin E, et al. Distressed high utilizers of medical care: DSM-III-R diagnoses and treatment needs. Gen Hosp Psychiatry 1990;12:355-362.
24. Katzelnick D, Kobak KA, Jefferson JW, Greist JH, Depression in primary care: effect of identification and treatment on service utilization and quality of life. Presented at the NIMH Conference on Mental Health Services Research, 1995.
25. Clark D, VonKorff M, Saunders K, Baluch WM, Simon GE. A chronic disease score with empirically derived weights. Med Care 1995;33:783-795.
26. Starfield B, Weiner JP, Mumford L, Steinwachs DM. Ambulatory care groups: a categorization of diagnosis for research and management. Health Serv Res 1991;26:54-74.
27. Simon G, VonKorff M. Somatization and psychiatric disorder in the NIMH Epidemiologic Catchment Area Study. Am J Psychiatry 1991;148:1494-1500.
28. Barsky A. Amplification, somatization, and the somatoform disorders. Psychosomatics 1992; 33:28-34.
29. Goldberg DP, Blackwell B. Psychiatric illness in general practice: a detailed study using a new method of case identification. BMJ 1970;2:439-443.
30. Jameson J, Shuman LJ, Young WW. The effects of outpatient psychiatric utilization on the costs of providing third-party coverage. Med Care 1978;16:383-399.
31. Follette W, Cummings NA. Psychiatric services and medical utilization in a prepaid health plan setting. Med Care 1967;5:25-35.
32. Goldensohn S, Fink R. Mental health services for medicaid enrollees in a prepaid group practice plan. Am J Psychiatry 1979;136:160-164.
33. Hankin J, Kessler LG, Goldberg ID, Steinwachs DM, Starfield BH. A longitudinal study of offset in the use of nonpsychiatric services following specialized mental health care. Med Care 1983;21:1099-1110.
34. Mumford E, Schlesinger H, Glass G, Patrick C, Cuerdon T. A new look at evidence about reduced cost of medical utilization following mental health treatment. Am J Psychiatry 1984;141:1145-1149.
35. Goldberg I, Allen G, Kessler LG, Carey JF, Locke BZ, Cook WA. Utilization of medical services after short-term psychiatric therapy in a prepaid health plan setting. Med Care 1981;19:672-686.
36. Rost K, Smith R, Matthews DB, Guise B. The deliberate misdiagnosis of depression in primary care. Arch Fam Med 1994;3:333-337.
37. Strain J, Hammer JS, Fulop G. APM Task Force on Psychosocial Interventions in the General Hospital Inpatient Setting: a review of cost-offset studies. Psychosomatics 1994;35:253-262.
38. Johnstone A, Goldberg DP. Psychiatric screening in general practice: a controlled trial. Lancet 1976;20:605-609.
39. Zung W, Magill M, More JT, George DT. Recognition and treatment of depression in a family medical practice. J Clin Psychiatry 1983;44:3-6.
40. Dowrick C, Buchan I. Twelve month outcome of depression in general practice: does detection or disclosure make a difference? BMJ 1995;311:1274-1277.
41. Schulberg H, Block MR, Madonia MJ, Rodriguez E, Scott P, Lave J. Applicability of clinical pharmacotherapy guidelines for major depression in primary care settings. Arch Fam Med 1995;4:106-112.
42. Katon W, VonKorff M, Lin E, et al. Collaborative management to achieve treatment guidelines: impact on depression in primary care. JAMA 1995;273:1026-1031.
43. Simon G, Wagner E, VonKorff M. Cost-effectiveness comparisons using "real world" randomized trials: the case of new antidepressant drugs. J Clin Epidemiol 1995;48:363-373.
44. Wells K, Golding JM, Burnam A. Chronic medical conditions in a sample of the general population with anxiety, affective, and substance use disorders. Am J Psychiatry 1989;146:1440-1446.
45. Barsky A, Geringer E, Wool CA. A cognitive-educational treatment for hypochondriasis. Gen Hosp Psychiatry 1988;10:322-327.
46. Hellman C, Budd M, Borysenko J, McClelland DC, Benson H. A study of the effectiveness of two group behavioral medicine interventions for patients with psychosomatic complaints. Behav Med 1990;165-173.
47. Warwick H. A cognitive-behavioural approach to hypochondriasis and health anxiety. J Psychosom Res 1989;33:705-711.
48. Gask L, Goldberg D, Porter R, Creed F. The treatment of somatization: evaluation of a teaching package with general practice trainees. J Psychosom Res 1989;33:697-703.
49. Goldberg D, Gask L, O'Dowd T. The treatment of somatization: teaching techniques of reattribution. J Psychosom Res 1989;33:689-695.
50. Sackett D, Gent M. Controversy in counting and attributing events in clinical trials. N Engl J Med 1979;301:1410-1412.
51. Johnson J, Weissman M, Klerman G. Service utilization and social morbidity associated with depressive symptoms in the community. JAMA 1992;267:1478-1483.
52. Broadhead WE, Blazer DG, George LK, Tse CK. Depression, disability days and days lost from work in a prospective epidemiologic survey. JAMA 1990;264:2524-2528.
53. Wells K, Stewart A, Hays R. et al. The functioning and well-being of depressed patients: results from the Medical Outcome Study. JAMA 1989;262:914-919.
54. Chakrabarti S, Kulhara P, Verma SK. Extent and determinates of burden among families of patients with affective disorders. Acta Psychiatr Scand 1992;86:247-252.
55. Spitzer R, Kroenke K, Linzer M, et al. Health-related quality of life in primary care patients with mental disorders. JAMA 1995;274:1511-1517.